Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M111,432Revenue $M17,005Net Margin (%)12.2Z-Score503,319
Enterprise Value $M140,258EPS $3.0Operating Margin %14.1F-Score4
P/E(ttm))0Cash Flow Per Share $4.4Pre-tax Margin (%)14.7Higher ROA y-yN
Price/Book010-y EBITDA Growth Rate %7.1Quick Ratio-50.7Cash flow > EarningsY
Price/Sales4.55-y EBITDA Growth Rate %8.1Current Ratio0Lower Leverage y-yN
Price/Cash Flow9.7y-y EBITDA Growth Rate %-96,160.3ROA % (ttm)7.0Higher Current Ratio y-yN
Dividend Yield %1.5Insider Buy (3m)0ROE % (ttm)13.6Less Shares Outstanding y-yY
Payout Ratio %43.0Shares Outstanding M984ROI % (ttm)3.1Gross Margin Increase y-yN

Gurus Latest Trades with MDT

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
MDTJohn Hussman 2014-12-31 Buy 1.4%$61.81 - $75.57
($69.56)
$ 78.1912%New holding, 200000 sh.200,000
MDTVanguard Health Care Fund 2014-12-31 Add0.11%$61.81 - $75.57
($69.56)
$ 78.1912%Add 5.2%13,047,000
MDTRay Dalio 2014-12-31 Add0.01%$61.81 - $75.57
($69.56)
$ 78.1912%Add 35.45%36,632
MDTRuane Cunniff 2014-12-31 Reduce$61.81 - $75.57
($69.67)
$ 78.1912%Reduce -51.55%4,700
MDTPRIMECAP Management 2014-12-31 Reduce-0.74%$61.81 - $75.57
($69.56)
$ 78.1912%Reduce -37.1%18,578,166
MDTAndreas Halvorsen 2014-12-31 Sold Out -0.46%$61.81 - $75.57
($69.67)
$ 78.1912%Sold Out0
MDTJoel Greenblatt 2014-12-31 Reduce-0.3%$61.81 - $75.57
($69.67)
$ 78.1912%Reduce -96.05%19,608
MDTJean-Marie Eveillard 2014-12-31 Reduce-0.09%$61.81 - $75.57
($69.56)
$ 78.1912%Reduce -30.95%1,236,314
MDTMario Gabelli 2014-12-31 Reduce-0.01%$61.81 - $75.57
($69.56)
$ 78.1912%Reduce -75%10,000
MDTAndreas Halvorsen 2014-09-30 Buy 0.46%$61 - $66.53
($63.6)
$ 78.1923%New holding, 1841414 sh.1,841,414
MDTJoel Greenblatt 2014-09-30 Add0.3%$61 - $66.53
($63.6)
$ 78.1923%Add 5179.96%496,211
MDTHOTCHKIS & WILEY 2014-09-30 Add0.29%$61 - $66.53
($63.6)
$ 78.1923%Add 67.19%3,230,958
MDTRobert Olstein 2014-09-30 Add0.21%$61 - $66.53
($63.6)
$ 78.1923%Add 23.48%142,000
MDTRay Dalio 2014-09-30 Buy 0.01%$61 - $66.53
($63.6)
$ 78.1923%New holding, 27045 sh.27,045
MDTRuane Cunniff 2014-09-30 Buy $61 - $66.53
($63.6)
$ 78.1923%New holding, 9700 sh.9,700
MDTScott Black 2014-09-30 Sold Out -0.4%$61 - $66.53
($63.6)
$ 78.1923%Sold Out0
MDTRobert Olstein 2014-06-30 Buy 0.99%$58.05 - $64.67
($60.7)
$ 78.1929%New holding, 115000 sh.115,000
MDTJean-Marie Eveillard 2014-06-30 Buy 0.32%$58.05 - $64.67
($60.7)
$ 78.1929%New holding, 2098343 sh.2,098,343
MDTVanguard Health Care Fund 2014-06-30 Add0.18%$58.05 - $64.67
($60.7)
$ 78.1929%Add 9.39%12,402,000
MDTMario Gabelli 2014-06-30 Buy 0.01%$58.05 - $64.67
($60.7)
$ 78.1929%New holding, 40000 sh.40,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MDT is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
MDT John Hussman 2014-12-31200,0000.021.4New Buy
MDT Ray Dalio 2014-12-3136,63200.02+35.45%
MDT Vanguard Health Care Fund 2014-12-3113,047,0001.332.2+5.2%
MDT James Barrow 2014-12-3132,638,4543.323.2+0.49%
MDT Ken Fisher 2014-12-316,19300+0.45%
MDT Bill Nygren 2014-12-314,690,0000.482
MDT Dodge & Cox 2014-12-318,817,7730.90.59-0.53%
MDT HOTCHKIS & WILEY 2014-12-313,207,8840.330.81-0.71%
MDT John Keeley 2014-12-3133,18000.05-0.84%
MDT Robert Olstein 2014-12-31134,0000.011.2-5.63%
MDT Jean-Marie Eveillard 2014-12-311,236,3140.130.22-30.95%
MDT PRIMECAP Management 2014-12-3118,578,1661.891.4-37.1%
MDT Ruane Cunniff 2014-12-314,70000-51.55%
MDT Mario Gabelli 2014-12-3110,00000-75%
MDT Joel Greenblatt 2014-12-3119,60800.01-96.05%
MDT Andreas Halvorsen 2014-12-31000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


MDT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
OLEARY DENISE MDirector 2015-02-26Sell368$78.85-1.04view
OConnell Christopher JEVP & GroupPres Restora Therap 2015-02-19Sell50,361$78.22-0.24view
Kuntz RichardSrVP & Chief Scien, Clin, Reg 2014-12-19Sell12,855$74.544.68view
JACKSON SHIRLEY ADirector 2014-12-02Sell1,102$74.434.84view
OConnell Christopher JEVP & GroupPres Restora Therap 2014-11-28Sell42,921$73.955.52view
COYLE MICHAEL JEVP & Group Pres, Cardiac&Vasc 2014-10-09Sell370$64.0721.79view
OConnell Christopher JEVP & GroupPres Restora Therap 2014-10-06Sell15,388$64.9820.08view
COYLE MICHAEL JEVP & Group Pres, Cardiac&Vasc 2014-10-03Sell571$65.0319.99view
JACKSON SHIRLEY ADirector 2014-08-26Sell2,769$63.6622.57view
OConnell Christopher JEVP & GroupPres Restora Therap 2014-08-26Sell28,000$63.5722.75view

Press Releases about MDT :

    Quarterly/Annual Reports about MDT:

    News about MDT:

    Articles On GuruFocus.com
    Freedom Fund Update – March 2015 Mar 02 2015 
    Medtronic (MDT) Momentum at All-Time-High Levels, Knowles (KN) Rating Boosted Feb 21 2015 
    Medtronic Q3 Earnings 2015 Exceeds Market Expectations Feb 19 2015 
    A Robust Q4 Earnings Report From Boston Scientific Feb 10 2015 
    A Look at John Hussman's Recent Additions to His Portfolio Feb 06 2015 
    Steven Romick Shorts Alibaba, Medtronic in Q4 Jan 20 2015 
    Toro: A Quality Company with Strong Prospects Dec 19 2014 
    Edwards Lifesciences a Gold Standard in the Market Dec 16 2014 
    Boston Scientific Lost the First Place in Innovation Dec 11 2014 
    Vycor Value Could be Unlocked with These Major Partnerships Dec 05 2014 

    More From Our Partners
    3 Best Performing Stocks in February - Analyst Blog Mar 2 2015 - ZACKS

    More From Other Websites
    Medtronic EVP & CFO Gary Ellis to Speak at Barclays Healthcare Conference Mar 03 2015
    Medtronic EVP & CFO Gary Ellis to Speak at Barclays Healthcare Conference Mar 03 2015
    NuVasive: Court Overturns Medtronic Award Mar 03 2015
    Flex Pharma touts backing of Medtronic for product to treat cramps, muscle spasms Mar 03 2015
    U.S. court orders new trial for damages in Medtronic patent case Mar 02 2015
    Medtronic EVP & President Michael J. Coyle to Speak at Cowen Healthcare Conference Feb 27 2015
    Medtronic EVP & President Michael J. Coyle to Speak at Cowen Healthcare Conference Feb 27 2015
    Medtronic Announces Irish High Court Approval of Share Premium Reduction Feb 27 2015
    Medtronic Announces Irish High Court Approval of Share Premium Reduction Feb 27 2015
    MEDTRONIC INC Files SEC form 10-Q, Quarterly Report Feb 27 2015
    Medtronic's VenaSeal Wins FDA Nod for Vericose Veins Cure - Analyst Blog Feb 26 2015
    Tesla Motors (TSLA), Wal-Mart Stores (WMT), Medtronic PLC (MDT): Billionaire Jim Simons’ RenTech... Feb 26 2015
    Cyberonics Soars On Earnings Beat, Tax Inversion Deal Feb 26 2015
    Medtronic Adds Advanced Uro-Solutions to Neuromodulation - Analyst Blog Feb 24 2015
    Street Talk: CSC, STJ, AEO, RIG & PETX Feb 24 2015
    FDA Approves the VenaSeal(TM) Closure System for Treatment of Clinically Symptomatic Venous Reflux Feb 24 2015
    FDA Approves the VenaSeal(TM) Closure System for Treatment of Clinically Symptomatic Venous Reflux Feb 24 2015
    Medtronic's Artificial Pancreas Technology: Key to Diabetes Cure? - Analyst Blog Feb 23 2015
    3 Companies That Could Be Negatively Impacted By Johnson & Johnson Sale Of Cordis Feb 23 2015
    Medtronic buys maker of device for overactive bladders Feb 23 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK